Diagnostic News and Research

RSS

News outlets examine development of low-cost diagnostic tool, infectious disease surveillance

CNN examines the work of a Harvard University chemistry professor to "shrink a medical laboratory onto a piece of paper that's the size of a fingerprint and costs about a penny." According to George Whitesides, who created a prototype of the inexpensive paper "chip," the technology could be used to diagnose such diseases as HIV, malaria and tuberculosis in developing countries.

2 Mar 2010

Long-time cannabis use linked to psychosis-related outcomes

Young adults who have used cannabis or marijuana for a longer period of time appear more likely to have hallucinations or delusions or to meet criteria for psychosis, according to a report posted online today that will appear in the May print issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

2 Mar 2010

AdMeTech Foundation: Health care reform highlights need for better screening and prevention of prostate cancer

AdMeTech Foundation announced today that its President and CEO Dr. Faina Shtern will testify on March 4 before the U.S. House Committee on Oversight and Government Reform on how health care reform highlights the need for increased funding for research aimed at creating accurate, life-saving diagnostic tools for prostate cancer, which will improve screening, prevention, early detection and reduce health costs.

2 Mar 2010

febit releases updated Geniom Biochip containing 58 new miRNA sequences

febit today announced that an updated version of the company's Geniom Biochip containing 58 new discovered sequences in addition to all of the Homo sapiens microRNAs (miRNA) from miRBase version 14 is now available for cancer research. The 58 new miRNA sequences were found by deep sequencing in a miRNA discovery study performed on an Applied Biosystems SOLiD 3 sequencing system. All 58 miRNAs have been validated using the ABI TaqMan miRNA qRT-PCR assay and are now available for further studies using febit's microarray technology for miRNA-profiling.

2 Mar 2010

Gene research offers new hope for targeted breast cancer treatment

CANCER RESEARCH UK scientists have developed a system to identify faulty or missing genes that could prevent specific chemotherapy regimes from working. This opens the doors for targeted breast cancer treatment, according to research published in the Lancet Oncology* today (Monday).

2 Mar 2010

Isis Pharmaceuticals reports revenues of $32.3M for fourth-quarter 2009

Isis Pharmaceuticals, Inc. today announced its 2009 financial results and reviewed the highlights of the year. Isis achieved its 2009 financial guidance with pro forma net income of $166.9 million and a pro forma net operating loss (NOL) of $14.2 million compared with its guidance for the year of pro forma net income of more than $145 million and a pro forma NOL in the low to mid $20 million range. Isis also achieved its cash guidance by ending 2009 with $574.3 million of cash, cash equivalents and short-term investments significantly in excess of the $550 million projected.

1 Mar 2010

Toshiba America Medical Systems releases new cardiac CT software for Aquilion systems

Responding to the cardiac CT market’s need for superior image quality with lower radiation doses, Toshiba America Medical Systems, Inc., has unveiled new cardiac software enhancements available now for the Aquilion® ONE and Aquilion Premium CT systems. The new cardiac CT software package is designed to reduce radiation exposure while maintaining outstanding image quality.

1 Mar 2010

Axolotl to demonstrate Elysium Open Access platform during HIMSS 2010

Axolotl Corp., the most experienced health information exchange (HIE) solutions and services company, today announced that it will be demonstrating its standards-based service-oriented architecture (SOA) platform — Elysium Open Access, with live third party applications – in operation today. Elysium Open Access is a core part of Axolotl’s Elysium® Exchange HIE suite.

1 Mar 2010

Determining personal risk for genetic disorders essential

Genetic diseases affect an estimated 12 million Americans, yet according to a survey of 1,000 people conducted by the Genetic Disease Foundation (GDF), while two-thirds of those surveyed were willing to and saw the benefits of undergoing genetic testing, close to 80 percent had never talked to their physician about genetic screening – an inconsistency that can have serious implications on a person's overall health and the health of their immediate family members.

1 Mar 2010

New method using SGR to calculate rate of tumour growth developed

When treating cancer, it is an advantage to know the rate of growth of the cancer tumour. The standard method currently used to determine tumour growth, however, is erroneous. This is the conclusion of scientists at the University of Gothenburg, Sweden, who have developed a new model.

1 Mar 2010

Diagosis of head and neck lesions: Ultrasound-guided FNA better than standard palpation technique

Office-based, surgeon-performed, ultrasound-guided, fine needle aspiration (FNA) of head and neck lesions yields a statistically significant higher diagnostic rate compared to the standard palpation technique, indicates new research in the March 2010 issue of Otolaryngology - Head and Neck Surgery.

1 Mar 2010

Cotton thread as core material in 'lab-on-chip' devices to detect kidney failure and diabetes

A discovery by Monash University scientists could see humble cotton thread emerge as a core material in low-cost 'lab-on-chip' devices capable of detecting diseases such as kidney failure and diabetes.

27 Feb 2010

Researchers develop noninvasive infrared scanning system to diagnose melanomas

Johns Hopkins researchers have developed a noninvasive infrared scanning system to help doctors determine whether pigmented skin growths are benign moles or melanoma, a lethal form of cancer.

27 Feb 2010

Phadia AB plans to provide access for specialists to peanut allergen components

Today, at the 2010 Annual Meeting of The American Academy of Allergy, Asthma & Immunology (AAAAI) Phadia, the world leader in in vitro allergy diagnostics, announced plans to provide access for specialists to peanut allergen components. These plans support Phadia’s goal to expand collaboration with allergy and immunology specialists in order to advance the understanding of the clinical utility of allergen component test results.

27 Feb 2010

Federal officials focus on radiation practices at Florida clinic; Medical scan makers announce new efforts to prevent mistakes

Medicare regulations require that when patients receive some types of highly specialized cancer treatments, their radiation oncologist must be on site. But The New York Times reports that federal officials are investigating a Florida cancer clinic that billed Medicare for such treatments while the doctors were absent, sometimes on overseas trips.

27 Feb 2010

Magellan Health Services reports net revenue of $2.64 billion for year ended December 31, 2009

Magellan Health Services, Inc. today reported net revenue of $2.64 billion, net income of $106.7 million, or $3.01 per diluted common share, and segment profit of $227.2 million for the year ended December 31, 2009.

26 Feb 2010

Advances in surgical technology enable surgeons to perform many operations as outpatient procedures

Nearly 58 percent of the surgeries performed in hospitals were done as outpatient procedures, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

26 Feb 2010

UCLA School of Nursing selects CytoCore's PadKit Collection Kit for comparative cytology study of cervical cancer

CytoCore Inc., the developer of cost-effective products used in the practice of cytology for the detection and diagnosis of cancer and cancer related diseases, announced today that PadKit® Collection Kit, a transport kit using an intralabial device for the collection of gynecological samples, has been selected by the UCLA School of Nursing as the sample collection system for a comparative cytology study of cervical cancer.

26 Feb 2010

Genoptix to participate in Aetna's national provider network to offer laboratory and diagnostic services

Genoptix, Inc. today announced that it will participate in Aetna's (AET) national provider network to offer specialized laboratory and comprehensive diagnostic services designed to optimize the care of patients suffering from hematomalignancies, or cancers of the blood and bone marrow, including leukemia and lymphoma.

26 Feb 2010

Nanotechnology to tackle side effects and drug resistance in treatment of cancer

Huixin He, associate professor, nanoscale chemistry at Rutgers University, Newark, and Tamara Minko, professor at the Rutgers Ernest Mario School of Pharmacy, have developed a nanotechnology approach that potentially could eliminate the problems of side effects and drug resistance in the treatment of cancer. Under traditional chemotherapy, cancer cells, like bacteria, can develop resistance to drug therapy, leading to a relapse of the disease.

26 Feb 2010

Diagnostic News and Research

News outlets examine development of low-cost diagnostic tool, infectious disease surveillance

Long-time cannabis use linked to psychosis-related outcomes

AdMeTech Foundation: Health care reform highlights need for better screening and prevention of prostate cancer

febit releases updated Geniom Biochip containing 58 new miRNA sequences

Gene research offers new hope for targeted breast cancer treatment

Isis Pharmaceuticals reports revenues of $32.3M for fourth-quarter 2009

Toshiba America Medical Systems releases new cardiac CT software for Aquilion systems

Axolotl to demonstrate Elysium Open Access platform during HIMSS 2010

Determining personal risk for genetic disorders essential

New method using SGR to calculate rate of tumour growth developed

Diagosis of head and neck lesions: Ultrasound-guided FNA better than standard palpation technique

Cotton thread as core material in 'lab-on-chip' devices to detect kidney failure and diabetes

Researchers develop noninvasive infrared scanning system to diagnose melanomas

Phadia AB plans to provide access for specialists to peanut allergen components

Federal officials focus on radiation practices at Florida clinic; Medical scan makers announce new efforts to prevent mistakes

Magellan Health Services reports net revenue of $2.64 billion for year ended December 31, 2009

Advances in surgical technology enable surgeons to perform many operations as outpatient procedures

UCLA School of Nursing selects CytoCore's PadKit Collection Kit for comparative cytology study of cervical cancer

Genoptix to participate in Aetna's national provider network to offer laboratory and diagnostic services

Nanotechnology to tackle side effects and drug resistance in treatment of cancer

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News